The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2022 | Factors to consider when treating AML patients with complex karyotype
Eunice Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, briefly discusses the challenges with treating patients with acute myeloid leukemia (AML) with complex karyotype, and factors to consider when making treatment decisions. This interview took place at the 64th ASH Annual Meeting and Exposition congress held in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
